Usamah Sayed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Usamah Sayed has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Divya Singhal
3 shared publicationsNavin Kumar Tailor
3 shared publicationsAbdulqader Faris Abdulqader
2 shared publicationsDjamila Polatova
2 shared publicationsJasur Rizaev
2 shared publicationsAbdullah Saleh Al-Wajeeh
Anti-Doping Lab Qatar, Doha, Qatar
1 shared publication
Latest Publications
- 20 September 2026
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 127 (9) , e70125
Ferroptosis in the Tumor Immune Microenvironment: Mechanisms, Nanomedicine, and Immunotherapy
Ferroptosis, an iron‐dependent form of regulated cell death, is frequently dysregulated in both tumor and immune cells, contributing to tumor progression and limiting the effectiveness of cancer immunotherapy. Defining the molecular mechanisms that govern ferroptosis and its effects within the tumor immune microenvironment is critical for understanding its dual role in cancer biology. While modulation of ferroptosis presents a promising therapeutic strategy, non‐specific targeting may also impair normal tissues and tumor‐infiltrating immune cells. In this context, nanoparticle‐based delivery systems offer a potential approach to selectively regulate ferroptosis within tumors. Such strategies may enable precise remodeling of the tumor microenvironment and enhance antitumor immune responses, thereby improving immunotherapy outcomes. This review highlights the regulatory mechanisms linking ferroptosis and the tumor immune microenvironment, provides a critical discussion of recent developments in bionanomaterial‐based therapeutic platforms, and outlines the challenges and prospects for clinical application of these platforms for immunotherapy.
- 20 September 2026
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 127 (9) , e70125
Ferroptosis in the Tumor Immune Microenvironment: Mechanisms, Nanomedicine, and Immunotherapy
Ferroptosis, an iron‐dependent form of regulated cell death, is frequently dysregulated in both tumor and immune cells, contributing to tumor progression and limiting the effectiveness of cancer immunotherapy. Defining the molecular mechanisms that govern ferroptosis and its effects within the tumor immune microenvironment is critical for understanding its dual role in cancer biology. While modulation of ferroptosis presents a promising therapeutic strategy, non‐specific targeting may also impair normal tissues and tumor‐infiltrating immune cells. In this context, nanoparticle‐based delivery systems offer a potential approach to selectively regulate ferroptosis within tumors. Such strategies may enable precise remodeling of the tumor microenvironment and enhance antitumor immune responses, thereby improving immunotherapy outcomes. This review highlights the regulatory mechanisms linking ferroptosis and the tumor immune microenvironment, provides a critical discussion of recent developments in bionanomaterial‐based therapeutic platforms, and outlines the challenges and prospects for clinical application of these platforms for immunotherapy.
- Open Access
- 26 August 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (9) , e70455
Mechanistic Insights Into the Association Between Gut Microbiota Diversity and Atherosclerosis, Acute Coronary Syndrome, and Peripheral Arterial Disease Progression
Background: The gut microbiome has emerged as a potential contributor to cardiovascular diseases (CVDs), including atherosclerosis, acute coronary syndrome (ACS), and peripheral arterial disease (PAD). While observational studies link dysbiosis to CVD, causal relationships remain uncertain. Methods: This narrative review synthesizes evidence from human observational studies, clinical interventions, and experimental models to distinguish association from mechanistic plausibility and clinical causality. Literature was searched through July 2026 in PubMed/MEDLINE, Web of Science, and Scopus. Results: Microbial metabolites—including trimethylamine N‐oxide (TMAO), short‐chain fatty acids (SCFAs), bile acids, and lipopolysaccharide (LPS)—modulate endothelial function, immune cell programming, platelet activity, and plaque stability through receptor‐mediated signaling and epigenetic regulation. SCFAs demonstrate potentially protective effects via GPCR and HDAC pathways, while TMAO is associated with atherothrombotic risk. However, much mechanistic evidence derives from preclinical studies. Heterogeneity from diet, geography, host characteristics, renal function, and medications substantially influences microbiota‐CVD associations. Conclusion: The gut‐vascular connection is biologically plausible, but definitive clinical causality remains unproven. Microbiome‐directed therapies (dietary modulation, pre/pro/synbiotics, targeted metabolite inhibition) are investigational. Prospective, standardized, adequately powered human studies with clinically meaningful outcomes are essential before routine cardiovascular application.
- 26 August 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (9) , e70455
Open AccessMechanistic Insights Into the Association Between Gut Microbiota Diversity and Atherosclerosis, Acute Coronary Syndrome, and Peripheral Arterial Disease Progression
Background: The gut microbiome has emerged as a potential contributor to cardiovascular diseases (CVDs), including atherosclerosis, acute coronary syndrome (ACS), and peripheral arterial disease (PAD). While observational studies link dysbiosis to CVD, causal relationships remain uncertain. Methods: This narrative review synthesizes evidence from human observational studies, clinical interventions, and experimental models to distinguish association from mechanistic plausibility and clinical causality. Literature was searched through July 2026 in PubMed/MEDLINE, Web of Science, and Scopus. Results: Microbial metabolites—including trimethylamine N‐oxide (TMAO), short‐chain fatty acids (SCFAs), bile acids, and lipopolysaccharide (LPS)—modulate endothelial function, immune cell programming, platelet activity, and plaque stability through receptor‐mediated signaling and epigenetic regulation. SCFAs demonstrate potentially protective effects via GPCR and HDAC pathways, while TMAO is associated with atherothrombotic risk. However, much mechanistic evidence derives from preclinical studies. Heterogeneity from diet, geography, host characteristics, renal function, and medications substantially influences microbiota‐CVD associations. Conclusion: The gut‐vascular connection is biologically plausible, but definitive clinical causality remains unproven. Microbiome‐directed therapies (dietary modulation, pre/pro/synbiotics, targeted metabolite inhibition) are investigational. Prospective, standardized, adequately powered human studies with clinically meaningful outcomes are essential before routine cardiovascular application.
- 28 July 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 462 (1)
The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy
- 28 July 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 462 (1)
The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy
- 14 June 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 124
Gemcitabine-conjugated superparamagnetic iron oxide nanoparticles as a theranostic platform for MRI-guided magnetically targeted drug delivery and magnetic hyperthermia in pancreatic ductal Adenocarcinoma: Synthesis, characterization, and In vitro evaluation
- 14 June 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 124
Gemcitabine-conjugated superparamagnetic iron oxide nanoparticles as a theranostic platform for MRI-guided magnetically targeted drug delivery and magnetic hyperthermia in pancreatic ductal Adenocarcinoma: Synthesis, characterization, and In vitro evaluation
- Open Access
- 6 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (25) , 22916-22937
Illuminating MXene quantum dots: from surface chemistry to white lasing via photoluminescence mechanisms and spectral engineering
MXene quantum dots reveal tunable photoluminescence arising from surface chemistry and quantum confinement. The review deciphers emission mechanisms and strategies enabling multicolor, nonlinear, and white lasing applications.
- 6 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (25) , 22916-22937
Open AccessIlluminating MXene quantum dots: from surface chemistry to white lasing via photoluminescence mechanisms and spectral engineering
MXene quantum dots reveal tunable photoluminescence arising from surface chemistry and quantum confinement. The review deciphers emission mechanisms and strategies enabling multicolor, nonlinear, and white lasing applications.
- Open Access
- 31 March 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (1) , 947-956
The Effect of Zinc, Magnesium, and Copper Ions on the Activity of Alkaline Phosphatase Enzyme and Ceruloplasmin Protein in Hemolyzed Blood Samples
Hemolysis is a prevalent source of discrepancies in blood sampling. This study, involving 68 volunteers, systematically assessed the impact of hemolysis on Alkaline phosphatase (ALP) and Ceruloplasmin (Cp) levels, as well as the interplay of Zinc (Zn), Magnesium (Mg), and Copper (Cu) ions. Blood samples (n=68) were subjected to mechanical trauma to produce varying degrees of hemolysis - mild, moderate, and severe. After hemolysis occurred, the ALP activities were measured and recorded as 74.94±15.98 IU/L, 63.47±18.51 IU/L, and 50.29±17.23 IU/L respectively, against 89.47±18.13 IU/L in non-hemolyzed samples. Cp levels were found to decrease in a manner dependent on the degree of hemolysis to 38.53±5.14 mg/dL, 36.29±4.85 mg/dL, and 34.12±5.08 mg/dL from an initial 41.06±6.13 mg/dL in non-hemolyzed samples. The ion concentrations (Mg, Zn, Cu) in hemolyzed blood samples exhibited a direct correlation with the extent of hemolysis. When specific concentrations of these ions equivalent to those measured during severe blood hemolysis were introduced to non-hemolyzed samples, the activity of the ALP enzyme was notably reduced (p<0.001). The concentration of Cp decreased upon the addition of Mg and Zn alone. These findings highlight the crucial role of hemolysis and metal ions in influencing the level of ALP and Cp.
- 31 March 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (1) , 947-956
Open AccessThe Effect of Zinc, Magnesium, and Copper Ions on the Activity of Alkaline Phosphatase Enzyme and Ceruloplasmin Protein in Hemolyzed Blood Samples
Hemolysis is a prevalent source of discrepancies in blood sampling. This study, involving 68 volunteers, systematically assessed the impact of hemolysis on Alkaline phosphatase (ALP) and Ceruloplasmin (Cp) levels, as well as the interplay of Zinc (Zn), Magnesium (Mg), and Copper (Cu) ions. Blood samples (n=68) were subjected to mechanical trauma to produce varying degrees of hemolysis - mild, moderate, and severe. After hemolysis occurred, the ALP activities were measured and recorded as 74.94±15.98 IU/L, 63.47±18.51 IU/L, and 50.29±17.23 IU/L respectively, against 89.47±18.13 IU/L in non-hemolyzed samples. Cp levels were found to decrease in a manner dependent on the degree of hemolysis to 38.53±5.14 mg/dL, 36.29±4.85 mg/dL, and 34.12±5.08 mg/dL from an initial 41.06±6.13 mg/dL in non-hemolyzed samples. The ion concentrations (Mg, Zn, Cu) in hemolyzed blood samples exhibited a direct correlation with the extent of hemolysis. When specific concentrations of these ions equivalent to those measured during severe blood hemolysis were introduced to non-hemolyzed samples, the activity of the ALP enzyme was notably reduced (p<0.001). The concentration of Cp decreased upon the addition of Mg and Zn alone. These findings highlight the crucial role of hemolysis and metal ions in influencing the level of ALP and Cp.
- Open Access
- 25 June 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (2) , 1177-1185
Lipoprotein-Associated Phospholipase A2 and hs-CRP are Correlated with Anti-TPO Antibodies in Jordanian Non-Pregnant Women with Hashimoto’s Thyroiditis
Hashimoto’s thyroiditis (HT) is an autoimmune disorder characterized by elevated thyroid-stimulating hormone (TSH) levels. This research investigates the complex interaction between HT and cardiovascular risk in adult Jordanian non-pregnant women aged 20-50. Through a study involving 50 HT subjects and 40 healthy subjects, the levels of lipoprotein-associated phospholipase A2 (PLA2), high sensitivity C-reactive protein (hs-CRP), and anti-thyroid peroxidase (anti-TPO) antibodies were compared using ELISA methods and enzymatic colorimetric assays for lipid profiles. The results revealed significantly higher serum levels of hs-CRP, PLA2, and Anti-TPO in Hashimoto's patients, coupled with elevated cholesterol, triglyceride, and low-density lipoprotein (LDL) levels. Conversely, reduced levels of high-density lipoprotein (HDL) were observed in Hashimoto’s patients compared to healthy subjects. The study establishes a noteworthy correlation between thyroid autoimmunity, thyroid disease, PLA2, hs-CRP, and lipid profile, underscoring an increased cardiovascular risk in individuals with Hashimoto’s thyroiditis. The findings emphasize the prevalence of Anti-TPO antibodies in adult Jordanian non-pregnant women with Hashimoto’s thyroiditis.
- 25 June 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (2) , 1177-1185
Open AccessLipoprotein-Associated Phospholipase A2 and hs-CRP are Correlated with Anti-TPO Antibodies in Jordanian Non-Pregnant Women with Hashimoto’s Thyroiditis
Hashimoto’s thyroiditis (HT) is an autoimmune disorder characterized by elevated thyroid-stimulating hormone (TSH) levels. This research investigates the complex interaction between HT and cardiovascular risk in adult Jordanian non-pregnant women aged 20-50. Through a study involving 50 HT subjects and 40 healthy subjects, the levels of lipoprotein-associated phospholipase A2 (PLA2), high sensitivity C-reactive protein (hs-CRP), and anti-thyroid peroxidase (anti-TPO) antibodies were compared using ELISA methods and enzymatic colorimetric assays for lipid profiles. The results revealed significantly higher serum levels of hs-CRP, PLA2, and Anti-TPO in Hashimoto's patients, coupled with elevated cholesterol, triglyceride, and low-density lipoprotein (LDL) levels. Conversely, reduced levels of high-density lipoprotein (HDL) were observed in Hashimoto’s patients compared to healthy subjects. The study establishes a noteworthy correlation between thyroid autoimmunity, thyroid disease, PLA2, hs-CRP, and lipid profile, underscoring an increased cardiovascular risk in individuals with Hashimoto’s thyroiditis. The findings emphasize the prevalence of Anti-TPO antibodies in adult Jordanian non-pregnant women with Hashimoto’s thyroiditis.